Foundational research points to new therapeutic strategies for an emerging cancer drug
June 25, 2026
June 25, 2026
LA JOLLA, California, June 25 -- The Salk Institute for Biological Studies issued the following news release:
* * *
Foundational research points to new therapeutic strategies for an emerging cancer drug
*
HighlightsÂ
* Salk researchers investigated the impacts of entinostat, a drug that targets HDAC proteins, and found it inactivates DNA damage repair genes in pancreatic cancer cells
* The discovery led to new treatme . . .
* * *
Foundational research points to new therapeutic strategies for an emerging cancer drug
*
HighlightsÂ
* Salk researchers investigated the impacts of entinostat, a drug that targets HDAC proteins, and found it inactivates DNA damage repair genes in pancreatic cancer cells
* The discovery led to new treatme . . .